Nandan Padukone

Dr. Padukone is an experienced biotechnology entrepreneur and executive having founded, built, and advised several early and mid-stage biotechnology companies. Dr. Padukone has been Entrepreneur-in-Residence for the JDRF T1D Fund and led the development of the tech technology platform, clinical pipeline, and corporate strategy of IM Therapeutics prior to its financing. He also served as Senior Vice President of Business Development of NeuroBo Pharmaceuticals, a biotech company focused on novel therapies for neurodegenerative diseases. Previously, Dr. Padukone served as the Senior Vice President of Innovation at the Joslin Diabetes Center, an affiliate of Harvard Medical School, where he led strategic R&D alliances, company creation, clinical trial services, and healthcare partnerships in diabetes and related complications. Prior to Joslin, Dr. Padukone was President and CEO of Nuvera Biosciences, a biotech company he co-founded with MD Anderson Cancer Center to develop cancer diagnostics and personalized medicine for breast cancer. He is currently a Board Member of C2I, a biotechnology accelerator in the Greater Boston area and continues to advise entrepreneurs and early-stage ventures as a mentor with MassBio and the MIT Deshpande Center. Dr. Padukone holds a Ph.D. in biochemical engineering from North Carolina State University, an MBA from the University of Denver, an MS in chemical engineering from SUNY Buffalo, and a Bachelor of Technology in chemical engineering from the Indian Institute of Technology of Mumbai.